Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
USPH · against 456 other Healthcare companies of similar size
Ranked #199 of 457 · scores higher than 56% of peers
Bars: peers in each 10-point band of the valuation score43 peers with a valuation score of 60–69, including USPH · Click a bar to see the companies
Mainly thanks to its free cash flow yield, which is stronger than most Healthcare peers.
| Metric | USPH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 447 reported | 0.2% | 1.5% | 41% | 30% | |
| EBITDA yieldHigher is better · 461 reported | 5.3% | 4.3% | 56% | 50% | |
| Free cash flow yieldHigher is better · 208 reported | 5.1% | -1.6% | 76% | 20% | |
| Book yieldHigher is better · 452 reported | 35.5% | 40.7% | 44% | Context only |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score